IF=10.8997,Journal for Immunotherapy of Cancer,復(fù)旦大學(xué)附屬中山醫(yī)院,慢病毒;質(zhì)粒;siRNA.
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3